WO2002058673A8 - Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine - Google Patents
Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestineInfo
- Publication number
- WO2002058673A8 WO2002058673A8 PCT/EP2002/000515 EP0200515W WO02058673A8 WO 2002058673 A8 WO2002058673 A8 WO 2002058673A8 EP 0200515 W EP0200515 W EP 0200515W WO 02058673 A8 WO02058673 A8 WO 02058673A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- intestine
- conveying
- dietary compositions
- preparing pharmaceutical
- labile substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20010141 ITMI20010141A1 (en) | 2001-01-26 | 2001-01-26 | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL OR DIETETIC COMPOSITIONS FOR VEHICULATION IN THE INTESTINE OF LABILE SUBSTANCES |
ITMI01A000141 | 2001-01-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002058673A1 WO2002058673A1 (en) | 2002-08-01 |
WO2002058673A8 true WO2002058673A8 (en) | 2004-05-27 |
Family
ID=11446605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/000515 WO2002058673A1 (en) | 2001-01-26 | 2002-01-17 | Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine |
Country Status (2)
Country | Link |
---|---|
IT (1) | ITMI20010141A1 (en) |
WO (1) | WO2002058673A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008514198A (en) * | 2004-09-27 | 2008-05-08 | カーギル インコーポレイテッド | Cyclodextrin inclusion complex and method for producing the same |
USD736382S1 (en) | 2011-09-08 | 2015-08-11 | Ams Research Corporation | Surgical indicator with backers |
CN115349639B (en) * | 2022-10-17 | 2023-04-14 | 天津市宝恒生物科技有限公司 | Probiotic slow-release system for improving immunity and preparation method and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1537292A (en) * | 1991-04-16 | 1992-11-17 | Nippon Shinyaku Co. Ltd. | Method of manufacturing solid dispersion |
DE19619222A1 (en) * | 1996-05-13 | 1997-11-20 | Solvay Enzymes Gmbh & Co Kg | Enzyme granules for food technology applications |
JP2002521322A (en) * | 1998-07-23 | 2002-07-16 | ノボ ノルディスク アクティーゼルスカブ | Wet granulation process for the production of stable pharmaceutical formulations |
CA2360065A1 (en) * | 1999-01-22 | 2000-07-27 | Hunza Di Maria Carmela Marazzita S.A.S. | Lipoprotein complexes and compositions containing them |
JP2003521241A (en) * | 1999-10-29 | 2003-07-15 | フンツァ・ディ・ピストレシ・エルヴィラ・エ・チ・エッセ・ア・エッセ | Fibrous-lipid nutritional composite and compositions containing it |
-
2001
- 2001-01-26 IT ITMI20010141 patent/ITMI20010141A1/en unknown
-
2002
- 2002-01-17 WO PCT/EP2002/000515 patent/WO2002058673A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002058673A1 (en) | 2002-08-01 |
ITMI20010141A1 (en) | 2002-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2367412C2 (en) | Saturated powder that improves bioavailability and/or solubility of active substance, and method for making thereof | |
WO2002101412A3 (en) | Spray freeze-dried compositions | |
NZ506241A (en) | Solid cyclodextrin flavor delivery systems | |
PL345163A1 (en) | Sitostand formulation with emulsifier to reduce cholesterol absorption | |
WO2004105504A3 (en) | Dietary supplements and methods of preparing and administering dietary supplements | |
RU2001101910A (en) | METHOD OF OBTAINING LIPOS | |
MXPA04004730A (en) | Pharmaceutical compositions in particulate form. | |
ES2237492T3 (en) | METHOD FOR PREPARING ORTHOSILITIC ACID, ORTHOSILICICAL ACID AS OBTAINED AND ITS USE. | |
EA200301275A1 (en) | CAPSULES FOR INHALATION | |
HRP20050639A2 (en) | Novel dry powder inhalation system for transpulmonary administration | |
PL343342A1 (en) | Particulate active agent support for pulmonary application | |
WO2006040112A3 (en) | Taste-masking pharmaceutical compositions | |
DE602004023894D1 (en) | Dosage form with increased bioavailability | |
WO2008037359A3 (en) | Active ingredient containing stabilised solid medicinal forms and method for the production thereof | |
WO2002058673A8 (en) | Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine | |
HK1048064A1 (en) | Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses | |
MXPA04000211A (en) | Granulates containing liposoluble substances and a process for the preparation thereof. | |
US7189416B2 (en) | Method for stable and controlled delivery of (-)-hydroxycitric acid | |
AU2003296602A1 (en) | Quaternary compounds comprising propolis as the active substance | |
ATE291058T1 (en) | CROSSLINKER-FREE PREPARATIONS | |
NO20055016L (en) | Pharmaceutical composition as solid dosage form and method of preparation thereof | |
AU2003224107A1 (en) | Soluble composition containing sporopollenin and the use thereof | |
HK1096875A1 (en) | Compressed solid dosage form manufacturing processwell-suited for use with drugs of low aqueous sol ubility and compressed solid dosage forms made thereby | |
CA2406269A1 (en) | Process for drying amoxicillin | |
EP1214891A3 (en) | Oat and corn products containing absorbed ingredients and method of preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct app. not ent. europ. phase | ||
WR | Later publication of a revised version of an international search report | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |